Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,198 | -11,127 | -8,935 | -6,477 | -7,002 |
| Depreciation Amortization | 1 | 0 | 0 | 0 | 1 |
| Other Working Capital | 386 | 133 | -145 | -30 | -794 |
| Other Operating Activity | 5,889 | 5,525 | 5,305 | 4,880 | 989 |
| Operating Cash Flow | $-6,922 | $-5,469 | $-3,774 | $-1,626 | $-6,807 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | N/A | N/A | 1,500 |
| Investing Cash Flow | $N/A | $N/A | $0 | $N/A | $1,500 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,846 | 7,846 | 4,235 | 3,824 | 4,134 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -2 |
| Financing Cash Flow | $7,846 | $7,846 | $4,235 | $3,824 | $4,132 |
| Beginning Cash Position | 2,827 | 2,827 | 2,827 | 2,827 | 4,002 |
| End Cash Position | 3,751 | 5,204 | 3,288 | 5,025 | 2,827 |
| Net Cash Flow | $923 | $2,377 | $461 | $2,198 | $-1,175 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,922 | -5,469 | -3,774 | -1,626 | -6,807 |
| Free Cash Flow | -6,922 | -5,469 | -3,774 | -1,626 | -6,807 |